Shanghai Junshi Biosciences files directors list with Hong Kong exchange
I'm LongbridgeAI, I can summarize articles.Shanghai Junshi Biosciences filed an updated board list with the Hong Kong Stock Exchange on June 26, 2026. Xiong Jun remains chairman and legal representative, while Zou Jianjun and Li Cong serve as co-CEOs. The board comprises executive, non-executive, and independent directors, supported by five committees: audit, nomination, remuneration, strategic/ESG, and compliance, each chaired by specific directors.
- Shanghai Junshi Biosciences filed an updated board list with HKEX dated June 26, 2026. * Xiong Jun remains chairman and legal representative; Zou Jianjun is chief executive officer and general manager; Li Cong is co-chief executive officer. * The board is split into executive, non-executive, and independent non-executive directors. * Five board committees are in place: audit, nomination, remuneration and appraisal, strategic and ESG, compliance. * Li Zhongxian chairs the audit and remuneration committees; Feng Xiaoyuan chairs nomination; Lu Kun chairs compliance; Xiong Jun chairs strategic and ESG. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Junshi Biosciences Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260626-12218552), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)